Axonics Modulation

$44.47
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.34 (+3.11%) As of 5:47 PM UTC today

Why Robinhood?

You can buy or sell AXNX and other stocks, options, and ETFs commission-free!

About AXNX

Axonics Modulation Technologies, Inc. operates as a medical technology company, which engages in the design, development, and commercialization of sacral neuromodulation solutions. The firm focuses on the treatment of patients with overactive bladder (OAB), fecal incontinence (FI), and urinary retention (UR). It offers rechargeable SNM system, which delivers mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of OAB, FI, and UR. The company was founded by Guang Qiang Jiang, Danny L. Dearen, Timothy Deer, and Michael V. Williamson in March 2012 and is headquartered in Irvine, CA. The listed name for AXNX is Axonics Modulation Technologies, Inc. Common Stock.

CEO
Raymond Wayne Cohen
Employees
302
Headquarters
Irvine, California
Founded
2012
Market Cap
1.77B
Price-Earnings Ratio
Dividend Yield
Average Volume
536.69K
High Today
$45.06
Low Today
$43.15
Open Price
$43.44
Volume
145.80K
52 Week High
$52.10
52 Week Low
$15.25

Collections

AXNX Earnings

-$0.89
-$0.59
-$0.30
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 4, After Hours

You May Also Like